Evidence map›Paper›PMID 38188373›Full record

ArticleInfluenza and other respiratory viruses2024

Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center study.

Hidenori Takahashi, Hiroki Nagamatsu, Yuka Yamada, Naoya Toba, Mio Toyama-Kousaka, Shinichiro Ota, Miwa Morikawa, Masahiro Shinoda, Syunsuke Takano, Suzuko Fukasawa and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Analysis of influenza A, influenza B andFrontiers in public health · 2026
    Article
  5. Article
  6. Trends in Group AMedicina (Kaunas, Lithuania) · 2025
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Hidenori TakahashiDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Hiroki NagamatsuDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Yuka YamadaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Naoya TobaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Mio Toyama-KousakaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Shinichiro OtaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Miwa MorikawaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Masahiro ShinodaDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
Syunsuke TakanoDepartment of Infection Control Tokyo Shinagawa Hospital Tokyo Japan.
Suzuko FukasawaDepartment of Infection Control Tokyo Shinagawa Hospital Tokyo Japan.
Kaeyoung ParkDepartment of Infection Control Tokyo Shinagawa Hospital Tokyo Japan.
Takahiko YanoDepartment of Infection Control Tokyo Shinagawa Hospital Tokyo Japan.
Masamichi MineshitaDepartment of Respiratory Medicine St. Marianna University School of Medicine Kawasaki Japan.
Masaharu ShinkaiDepartment of Respiratory Medicine Tokyo Shinagawa Hospital Tokyo Japan.
New Tokyo Hospital · JPSt. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 pandemic led to significant reductions in influenza detection worldwide, fueling debates on whether influenza truly ceased circulating in communities. The number of influenza cases decreased significantly in Japan, raising concerns about the potential risk of decreased immunity to influenza in the population. Our single-center study aimed to investigate influenza trends before and during the COVID-19 pandemic in Tokyo, Japan. Materials and Methods: This cross-sectional study included patients of all ages who visited Tokyo Shinagawa Hospital between April 1, 2018, and March 31, 2023. Influenza and COVID-19 tests were conducted using Quick Navi-Flu2 and polymerase chain reaction (PCR). We analyzed data from before and during the COVID-19 epidemic, based on patient background, hospitalization, and deaths, collected from medical records. Results: A total of 12 577 influenza tests were conducted, with approximately 100 tests consistently performed each month even in the influenza off-season. Throughout the observation period, 962 positive cases were identified. However, no cases were observed for 27 months between March 2020 and November 2022. Influenza A cases were reobserved in December 2022, followed by influenza B cases in March 2023, similar to the influenza incidence reports from Tokyo. The positivity rate during the 2022-2023 winter season was lower than before the COVID-19 epidemic and decreased in elderly patients, with no hospitalizations or deaths observed. Conclusion: This single-center study provided actual trend data for influenza patients before and during COVID-19 outbreaks in Tokyo, which could offer insights into the potential impact and likelihood of influenza virus infection in Japan.

Indexed as

COVID-19Influenza, HumanOrthomyxoviridaeAgedCross-Sectional StudiesHumansJapanPandemicsSeasonsTokyoCOVID‐19 pandemicimmunityinfluenza trendspopulation healthQuick Navi‐Flu2

Identifiers

PMID38188373
PMCPMC10767599
OpenAlexW4390614634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.